共 309 条
[1]
Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108
[2]
Bray F(2002)Simplified staging for hepatocellular carcinoma J Clin Oncol 20 1527-1536
[3]
Ferlay J(1999)Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329-338
[4]
Pisani P(1999)Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 62-67
[5]
Vauthey JN(2000)Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival Hepatology 32 233-238
[6]
Lauwers GY(2009)Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 25-34
[7]
Esnaola NF(2017)Sorafenib versus hepatic arterial infusion chemotherapy as initial treatment for hepatocellular carcinoma with advanced portal vein tumor thrombosis Liver Cancer 6 275-286
[8]
Do KA(2013)Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis Gut Liver 7 696-703
[9]
Belghiti J(2011)Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience J Am Coll Surg 212 796-803
[10]
Mirza N(2009)Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein J Gastrointest Surg 13 1921-1928